GSK will acquire liver-disease treatment efimosfermin from Boston Pharmaceuticals for up to $2 billion to expand its portfolio. The British pharma giant said Wednesday that it will pay the U.S.

DHL Group, the world’s leading logistics provider, has signed a strategic Memorandum of Understanding (MOU) with Boston ...